20 May 2013
Keywords: roche, mabthera, yields, strong, data, cll, early
Article | 17 December 2007
Early results from two Phase II trials tracking the outcome of patients with chronic lymphocytic leukemia treated with Roche's MabThera
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 December 2007
17 May 2013
© 2013 thepharmaletter.com